Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Marton Suppan is the Co-founder and CEO of Turbine.AI, a company at the forefront of revolutionizing cancer research and drug discovery through the use of simulated cell biology. With a robust background in software engineering and entrepreneurial leadership, Marton has spearheaded Turbine.AI's mission to create dynamic digital models of cancer on a molecular level, aiming to identify optimal personalized treatment strategies and accelerate the development of new therapies. His journey includes hands-on software development roles prior to co-founding Turbine, giving him a deep understanding of the technological underpinnings of his current venture. He is passionate about leveraging cutting-edge artificial intelligence and biological simulation to tackle one of humanity's most complex medical challenges, making a significant impact on oncology and patient outcomes. Marton is also recognized for his ability to build and lead high-performing teams in the demanding intersection of biotech and AI.
Marton Suppan's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Co-founded Turbine.AI in 2015, a company that has since raised significant venture capital (including a notable Series A round) to develop its AI-powered cell simulation platform. Under his leadership, Turbine.AI partners with leading pharmaceutical companies to guide drug discovery and development in oncology.
Recognized in the Forbes 30 Under 30 Europe list in 2018 for the Science and Healthcare category, highlighting his impactful work and innovation in applying AI to cancer research through Turbine.AI.
Led the development and advancement of Turbine.AI's core technology, the Simulated Cell™ platform, which creates digital twins of cancer cells to predict treatment efficacy and uncover novel therapeutic targets, thereby de-risking and accelerating the drug development pipeline.
Frequently invited to speak at international conferences and industry events on the topics of artificial intelligence in drug discovery, personalized medicine, and the future of oncology research, sharing insights from Turbine.AI's innovative approach.
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Peak is a Decision Intelligence platform that embeds AI across the enterprise to drive commercial outcomes. It helps businesses make consistently great decisions by providing a centralized platform for data, AI models, and applications, enabling faster and more accurate insights for sales, marketing, supply chain, and operations. Peak aims to empower businesses of all sizes to leverage artificial intelligence for improved efficiency and growth.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.